Healthcare experts discuss the care of the elderly in haemato-oncology, looking at the current situation across Europe and what is needed to change the treatment of older patients.
This interview is supported by an unrestricted educational grant from Celgene.
Click on the links below to see more from the participants in this round table debate:
Prof. Sullivan talks to ecancertv about ageism in cancer treatment.
Prof. Sullivan talks about innovation in cancer drug development.
Prof. Sullivan discusses UK cancer reform strategy.
Prof. Sullivan speaks about prioritisation in cancer research.
A presentation from Prof. Sullivan about cancer research priorities.
Prof. Fenaux discusses myelodysplastic syndromes (MDS).
Prof. Fenaux speaks about innovation in the treatment of MDS.
Prof. Fenaux on the epigenetics of MDS.
Prof. Fenaux explains the benefits of azacitidine for treatment of MDS.